Edit
Probiodrug AG
http://www.probiodrug.com/Last activity: 15.04.2019
Probably Closed - Reference to GoDaddy
We are passionate about creating small molecule medications by building on our in-depth understanding of pathologic pathways with a single goal in mind: improving the lives of all those who are affected by severe diseases.
Total raised: $19.41M
Founded date: 1997
Investors 1
| Date | Name | Website |
| - | TVM Capita... | tvm-lifesc... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.01.2012 | - | $19.41M | - |
Mentions in press and media 3
| Date | Title | Description |
| 15.04.2019 | Probiodrug wirbt EUR 8,2 Mio mittels erfolgreicher Privatplatzierung von neuen Aktien ein | Probiodrug wirbt EUR 8,2 Mio mittels erfolgreicher Privatplatzierung von neuen Aktien ein HALLE (SAALE), Deutschland, 15. APRIL 2019 – Die Probiodrug AG (Euronext Amsterdam: PBD, ISIN: DE0007921835) gibt den erfolgreichen Abschluss einer K... |
| 04.01.2012 | Probiodrug AG Raises Additional EUR15 Million to Advance Its Clinical Program | HALLE/SAALE, Germany, Jan. 4 2012 – Probiodrug AG today announced it has secured EUR15 million additional financing for the ongoing development of its glutaminyl cyclase (QC) inhibitor program. The lead compound, PQ912, its first QC inhibit... |
| 02.11.2009 | Germany, Probiodrug Closes €36M Series B Financing Round | Probiodrug AG, a Halle (Saale), Germany-based biotech company developing novel concepts and products for the treatment of neurodegenerative and inflammatory diseases with a particular focus on Alzheimer’s disease, closed a Series B financin... |